ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.623,08
0,00%
S&P 500
6.039,31
-0,47%
Dow Jones
44.713,52
-0,31%
Euro vs US Dollar
1,0415
-0,09%
Bitcoin
105.013,02
1,23%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. HilleVax Inc (HLVX)

  7. HilleVax Inc (HLVX) News

HLVX

HilleVax (HLVX)

HilleVax Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:HLVX
DatumZeitQuelleÜberschriftSymbolFirma
05/12/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
07/11/202414h10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HLVXHilleVax Inc
07/11/202414h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
07/11/202414h00GlobeNewswire Inc.HilleVax Reports Third Quarter 2024 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
16/10/202422h40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
09/08/202401h20GlobeNewswire Inc.HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
31/07/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
31/07/202422h00GlobeNewswire Inc.HilleVax Announces Reduction in ForceNASDAQ:HLVXHilleVax Inc
23/07/202422h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
09/07/202412h54IH Market NewsBP Slashes Profit Forecast by $700 Million; Morgan Stanley Predicts S&P 500 10% Drop, and More NewsNASDAQ:HLVXHilleVax Inc
08/07/202413h40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
08/07/202413h30GlobeNewswire Inc.HilleVax Reports Topline Data from NEST-IN1 Phase 2b Clinical Study of HIL-214 in InfantsNASDAQ:HLVXHilleVax Inc
10/06/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
10/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:HLVXHilleVax Inc
09/05/202422h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HLVXHilleVax Inc
09/05/202422h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
09/05/202422h05GlobeNewswire Inc.HilleVax Reports First Quarter 2024 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
20/03/202421h00GlobeNewswire Inc.HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
13/02/202401h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HLVXHilleVax Inc
05/02/202422h05GlobeNewswire Inc.HilleVax to Present at Guggenheim 6th Annual Biotechnology ConferenceNASDAQ:HLVXHilleVax Inc
02/02/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HLVXHilleVax Inc
26/01/202423h00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:HLVXHilleVax Inc
18/01/202413h49Dow Jones NewsHilleVax Taps Sean McLoughlin as Chief Operating OfficerNASDAQ:HLVXHilleVax Inc
18/01/202413h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
18/01/202413h00GlobeNewswire Inc.HilleVax Announces Executive Management Appointment of Sean McLoughlin as Chief Operating OfficerNASDAQ:HLVXHilleVax Inc
08/01/202413h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
08/01/202413h00GlobeNewswire Inc.HilleVax and Kangh Announce Exclusive License Agreement for Hexavalent VLP Norovirus Vaccine Candidate Outside of ChinaNASDAQ:HLVXHilleVax Inc
04/01/202400h28GlobeNewswire Inc.HilleVax to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:HLVXHilleVax Inc
18/12/202323h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HLVXHilleVax Inc
18/12/202323h28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:HLVXHilleVax Inc
 Showing the most relevant articles for your search:NASDAQ:HLVX

Kürzlich von Ihnen besucht

AMEX
XLV
Health Care Select Sector
TG
D7G
Nel ASA
AMEX
XLF
Financial Select Sector
FX
EURGBP
Euro vs Sterling
TG
LHA
Deutsche Lufthansa
NASDAQ
TSLA
Tesla
DBI
MDAX
MDAX
NASDAQ
AAPL
Apple
TG
ALV
Allianz
NASDAQ
NVDA
NVIDIA
FX
EURJPY
Euro vs Yen
NYSE
NKE
Nike
NYSE
KO
Coca Cola
NYSE
MRK
Merck
DBI
DAX
DAX
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten